Author:
Hussein Ahmed A.,Shabir Usma,Mahmood Abdul Wasay,Harrington Grace,Khan Mohammad,Ahmad Ali,Howlader Muhsinah,Colan Nicholas,Shah Ayat A.,Ghadersohi Sarah,Jing Zhe,Xu Bo,Sule Nobert,Kauffman Eric,Kuettel Michael,Guru Khurshid
Funder
Roswell Park Alliance Foundation
Reference27 articles.
1. Quality-of-life effects of prostate-specific antigen screening;Heijnsdijk;N Engl J Med,2012
2. NCCN guidelines version 1.2022 prostate cancer early detection 2022 Accessed July 23, 2022 2022. Available at: https://www.nccn.org/professionals/physician_gls/pdf/prostate_detection.pdf.
3. NCCN guidelines version 4.2022 prostate cancer 2022 Accessed July 23, 2022 2022. Available at: https://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf.
4. Time trends and variation in the use of active surveillance for management of low-risk prostate cancer in the US;Cooperberg;JAMA Netw Open,2023
5. Trends in the use of active surveillance and treatments in Medicare beneficiaries diagnosed with localized prostate cancer;Liu;Urol Oncol,2021